SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.084
EU - Europa 1.389
AS - Asia 1.239
SA - Sud America 84
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 6.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.065
CN - Cina 501
SG - Singapore 473
UA - Ucraina 312
IT - Italia 271
DE - Germania 214
TR - Turchia 145
GB - Regno Unito 144
FI - Finlandia 98
PL - Polonia 89
BR - Brasile 77
SE - Svezia 69
HK - Hong Kong 37
EE - Estonia 36
BE - Belgio 26
ID - Indonesia 25
RU - Federazione Russa 23
NL - Olanda 22
CZ - Repubblica Ceca 19
CA - Canada 17
FR - Francia 17
IR - Iran 10
VN - Vietnam 10
ES - Italia 7
IQ - Iraq 7
MY - Malesia 7
IE - Irlanda 6
LT - Lituania 6
RO - Romania 6
SD - Sudan 6
ZA - Sudafrica 6
BG - Bulgaria 5
KR - Corea 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
EU - Europa 4
IN - India 4
AR - Argentina 3
AU - Australia 3
PK - Pakistan 3
PT - Portogallo 3
GR - Grecia 2
JP - Giappone 2
MA - Marocco 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
RS - Serbia 1
UY - Uruguay 1
Totale 6.825
Salva come PNG Salva come JPEG
Città #
Woodbridge 521
Fairfield 340
Jacksonville 330
Chandler 324
Houston 301
Ann Arbor 281
Santa Clara 270
Singapore 220
Ashburn 207
Wilmington 139
Ferrara 127
Cambridge 113
Nanjing 110
Seattle 107
Izmir 99
Beijing 90
Princeton 81
Warsaw 76
Boardman 66
Dearborn 57
Milan 44
Nanchang 37
Shanghai 37
Shenyang 35
Hong Kong 33
San Diego 33
Helsinki 31
Changsha 28
Brussels 26
Tianjin 25
Los Angeles 23
Bremen 19
Jakarta 19
Brno 18
Jiaxing 17
Hebei 16
Bologna 15
Munich 15
Ningbo 15
Orange 15
Addison 14
Jinan 13
Norwalk 13
San Mateo 12
New York 11
Redwood City 11
Augusta 10
London 10
Mountain View 10
Auburn Hills 9
Dong Ket 9
Kraków 9
Washington 8
Des Moines 7
Falls Church 7
Frankfurt am Main 7
Leawood 7
Philadelphia 7
Casalecchio Di Reno 6
Dublin 6
Falkenstein 6
Guangzhou 6
Montréal 6
Chicago 5
Indiana 5
Lübeck 5
Ottawa 5
Tappahannock 5
Wageningen 5
Ardabil 4
Dronten 4
Düsseldorf 4
Ferrara di Monte Baldo 4
Fuzhou 4
Haikou 4
Khartoum 4
Nuremberg 4
Rome 4
Shah Alam 4
Taizhou 4
Toronto 4
Zhengzhou 4
Calderara Di Reno 3
Changchun 3
Curitiba 3
Espoo 3
Hefei 3
Kunming 3
Las Vegas 3
North Bergen 3
Paris 3
Senador Canedo 3
São Paulo 3
Taipei 3
Tuen Mun 3
Verona 3
Amsterdam 2
Assago 2
Baghdad 2
Chisinau 2
Totale 4.696
Salva come PNG Salva come JPEG
Nome #
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 172
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 167
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 164
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 148
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 139
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 137
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 136
null 128
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 126
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 121
Mutual communication of envelope glycoproteins of paramixoviruses 119
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 118
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 113
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 112
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 111
null 110
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 109
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 108
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 107
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 106
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 106
null 104
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 102
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 101
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 101
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 98
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 98
null 97
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 97
Substrate binding to 6-phosphogluconate dehydrogenase 95
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 93
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 90
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 89
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 89
null 88
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 86
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 86
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 86
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 85
Biochemical study in adult population with stroke in Ferrara, Fabry disease 82
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 81
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 80
Domain structure of the hemagglutinin-neuraminidase from sendai virus 80
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 79
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 78
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 77
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 77
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 77
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 75
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 73
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 71
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 70
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 69
Purification of transglutaminase enzyme from L. infantum promastigotes 68
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 67
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 67
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 67
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 66
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 65
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 63
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 63
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 62
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 62
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 61
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 57
The influence of different replacement solutions on neutrophils response 55
MMP-9 isoforms in serum of Multiple Sclerosis patients 54
null 53
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 52
null 49
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 48
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 47
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 45
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 39
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 39
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 38
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 38
Effects of anticoagulants on the activity of gelatinases 37
Effects of anticoagulants on the activity of gelatinases 36
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 30
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 28
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 23
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 23
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 22
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 14
Totale 6.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 0 0 0 120 55 21
2020/2021887 79 79 32 79 45 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.262 49 42 153 73 216 152 68 98 263 148 0 0
Totale 6.949